These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Determination of endogenous middle molecules in normal and uremic body fluids. Fürst P, Zimmerman L, Bergström J. Clin Nephrol; 1976 Apr; 3(2):178-88. PubMed ID: 1277595 [Abstract] [Full Text] [Related]
4. [Retention of medium sized molecules in uremic serum]. Dall'aglio P, Buzio C, Cambi V, Arisi L, Migone L. Proc Eur Dial Transplant Assoc; 1972 Apr; 9():409-16. PubMed ID: 4668919 [No Abstract] [Full Text] [Related]
7. Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum. Bourgoignie J, Klahr S, Bricker NS. J Clin Invest; 1971 Feb; 50(2):303-11. PubMed ID: 5540168 [Abstract] [Full Text] [Related]
8. Gel-filtration on psoriasic and uremic serum and dialysis fluid. Lamperi S, Buoncristiani U, Carozzi S, Cozzari M, Icardi A, Trasforini D. Artif Organs; 1981 Feb; 4 Suppl():156-9. PubMed ID: 7295083 [Abstract] [Full Text] [Related]
9. Low molecule and middle molecule metabolites with haemodynamic activity in the ultrafiltrate from uraemic patients (author's transl). Pogglitsch H, Petek W, Waller J, Stübchen-Kirchner H. Wien Klin Wochenschr; 1977 Dec 23; 89(24):812-9. PubMed ID: 595605 [Abstract] [Full Text] [Related]
10. Evaluation of dialysis treatment in uremic patients by gel filtration of serum. Osada J, Gea T, Sanz C, Millan I, Botella J. Clin Chem; 1990 Nov 23; 36(11):1906-10. PubMed ID: 2242568 [Abstract] [Full Text] [Related]
11. Middle molecular weight substances and uremic polyneuropathy. Dukanović L, Petrović J, Potić J. Acta Med Iugosl; 1990 Nov 23; 44(2):117-28. PubMed ID: 2162129 [Abstract] [Full Text] [Related]
13. Preparative isolation of middle molecular weight fractions from the hemofiltrate of patients with chronic uremia. Brunner H, Mann H, Essers U, Schultheis R, Byrne T, Heintz R. Artif Organs; 1978 Nov 23; 2(4):375-7. PubMed ID: 743009 [Abstract] [Full Text] [Related]
16. The effect of hemodialysis on endogenous middle molecules in uremic patients. Asaba H, Fürst P, Oulés R, Yahiel V, Zimmerman L, Bergström J. Clin Nephrol; 1979 May 23; 11(5):257-66. PubMed ID: 455822 [Abstract] [Full Text] [Related]
17. Technical aspects on middle molecules: separation, isolation, and identification. Cueille G, Man NK, Sausse A, Farges JP, Funck-Brentano JL. Artif Organs; 1981 May 23; 4 Suppl():8-12. PubMed ID: 7295100 [Abstract] [Full Text] [Related]
18. [An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia]. Popławski A, Myśliwiec M. Pol Merkur Lekarski; 1996 Oct 23; 1(4):246-8. PubMed ID: 9156935 [Abstract] [Full Text] [Related]
19. Chemical analytic approaches to the definition of uremic toxins. Furst P, Bergstrom J, Gordon A, Zimmermann L. Ateneo Parmense Acta Biomed; 1975 Oct 23; 46(5):307-16. PubMed ID: 1232992 [Abstract] [Full Text] [Related]
20. Effect of urine metabolites from healthy and uremic subjects on gluconeogenesis in slices of rat kidney cortex and liver. Lamberts B, Brunner H, Ochs HG, Spellerberg P, Heintz R. Clin Nephrol; 1976 Nov 23; 6(5):465-72. PubMed ID: 991468 [Abstract] [Full Text] [Related] Page: [Next] [New Search]